Top Heal Care Stocks For 2019

tags:STAA,PETM,ADAP,

Markets are digesting news that Bitcoin futures hit an all-time high on Wednesday, according to data provided by U.S. exchanges CME and CBOE.

Roughly $670 million in contracts were exchanged on the markets. CME said that roughly 11,000 contracts (worth 56,100 BTC) were traded on April 25. Futures trading is up 44% in April compared to trading in March.

Here is a recap of the top five cryptocurrencies by market cap as of 3:30 p.m. EDT.

Cryptocurrency Market Cap Price Change (24h) Bitcoin (BTC) $156,772,914,656 $9,220.77 +3.22% Ethereum (ETH) $66,530,143,084 $671.44 +5.72% Ripple (XRP) $33,211,912,986 $0.84 +2.59% Bitcoin Cash (BCH) $23,761,413,354 $1,389.79 +3.84% EOS $14,159,677,774 $17.25 +16.43%

Now here's a closer look at today's Money Morning cryptocurrency insight, the most important cryptocurrency updates you need to know…

Top Heal Care Stocks For 2019: STAAR Surgical Company(STAA)

Advisors' Opinion:

• [By Keith Speights]

  Three big healthcare winners this week were STAAR Surgical (NASDAQ:STAA), Tenet Healthcare (NYSE:THC), and Portola Pharmaceuticals (NASDAQ:PTLA). Each of these stocks jumped more than 24% over the last few days. Are STAAR Surgical, Tenet, and Portola smart picks for investors after the stocks' huge gains?

• [By Keith Speights]

  Shares of STAAR Surgical Company (NASDAQ:STAA) were up 21.5% as of 11:25 a.m. EDT on Thursday. The big jump occurred after the maker of implantable lenses announced its second-quarter earnings results on Wednesday evening.

• [By Motley Fool Transcribers]

  Staar Surgical Co  (NASDAQ:STAA)Q4 2018 Earnings Conference CallFeb. 21, 2019, 4:30 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Chris Lange]

  STAAR Surgical Co. (NASDAQ: STAA) shares made a handy gain on Friday after the firm announced a key approval by the U.S. Food and Drug Administration (FDA).

• [By Max Byerly]

  Shares of STAAR Surgical (NASDAQ:STAA) have earned a consensus rating of “Buy” from the eight brokerages that are covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $38.75.

Top Heal Care Stocks For 2019: PetSmart Inc(PETM)

Advisors' Opinion:

• [By Joseph Griffin]

  An issue of PetSmart, Inc. (NASDAQ:PETM) bonds fell 1.6% as a percentage of their face value during trading on Wednesday. The high-yield debt issue has a 8.875% coupon and is set to mature on June 1, 2025. The debt is now trading at $49.19 and was trading at $55.47 one week ago. Price changes in a company’s bonds in credit markets often predict parallel changes in its stock price.

• [By Shane Hupp]

  An issue of PetSmart, Inc. (NASDAQ:PETM) debt rose 1% against its face value during trading on Monday. The high-yield debt issue has a 8.875% coupon and is set to mature on June 1, 2025. The debt is now trading at $67.50 and was trading at $66.25 last week. Price moves in a company’s debt in credit markets often anticipate parallel moves in its share price.

• [By Shane Hupp]

  An issue of PetSmart, Inc. (NASDAQ:PETM) bonds fell 1.5% against their face value during trading on Tuesday. The high-yield issue of debt has a 7.125% coupon and is set to mature on March 15, 2023. The debt is now trading at $71.75 and was trading at $74.97 one week ago. Price changes in a company’s bonds in credit markets often predict parallel changes in its share price.

Top Heal Care Stocks For 2019: Adaptimmune Therapeutics plc(ADAP)

Advisors' Opinion:

• [By Logan Wallace]

  Adaptimmune Therapeutics (NASDAQ:ADAP) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

• [By ]

  Adaptimmune Therapeutics (ADAP) : "If you've speculated on this one, you've won. Let's move on."

  Icahn Enterprises (IEP) : "I don't really know what they own so I can't recommend it."

• [By Stephan Byrd]

  Adaptimmune Therapeutics (NASDAQ:ADAP) was downgraded by stock analysts at TheStreet from a “c-” rating to a “d+” rating in a research report issued to clients and investors on Monday.

• [By ]

  Cramer was bearish on Chesapeake Energy (CHK) , Adaptimmune Therapeutics (ADAP) , Icahn Enterprises (IEP) , Bristol-Myers Squibb (BMY) , Quad/Graphics (QUAD) , Spectra Energy Partners (SEP) and L Brands (LB) .